NASDAQ:ADMA

ADMA Biologics Insider Trades

$1.76
-0.11 (-5.88 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.75
Now: $1.76
$1.85
50-Day Range
$1.67
MA: $2.12
$2.64
52-Week Range
$1.57
Now: $1.76
$4.20
Volume1.57 million shs
Average Volume3.63 million shs
Market Capitalization$213.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.84

Insider Trades

ADMA Biologics (NASDAQ:ADMA) Insider Buying and Selling Activity

Insider Ownership Percentage: 11.70%
Insider Buying (Last 12 Months): $121,386.00
Insider Selling (Last 12 Months): $0.00

Insider Buying and Selling by Quarter


ADMA Biologics (NASDAQ ADMA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2020Jerrold B. GrossmanDirectorBuy5,000$2.22$11,100.00  
9/10/2020Jerrold B. GrossmanDirectorBuy5,000$2.22$11,100.00  
9/8/2020James MondCMOBuy4,000$2.20$8,800.00  
8/21/2020Jerrold B. GrossmanDirectorBuy5,300$2.56$13,568.00  
8/12/2020Jerrold B. GrossmanDirectorBuy10,200$2.89$29,478.00  
8/11/2020Brian LenzCFOBuy4,000$2.97$11,880.00  
8/10/2020Adam S. GrossmanCEOBuy5,000$3.06$15,300.00  
8/10/2020James MondCMOBuy7,000$2.88$20,160.00  
3/19/2020Perceptive Advisors LlcMajor ShareholderBuy500,000$2.10$1,050,000.00  
2/11/2020Adam S GrossmanCEOBuy28,571$3.50$99,998.5066,098  
2/11/2020Brian LenzCFOBuy7,142$3.50$24,997.0032,142  
2/11/2020James MondCMOBuy4,285$3.50$14,997.5022,174  
2/11/2020Lawrence P GuiheenDirectorBuy20,000$3.50$70,000.0070,000  
2/11/2020Perceptive Advisors LlcMajor ShareholderBuy4,563,700$3.50$15,972,950.00  
6/6/2019Biotest Divestiture TrustMajor ShareholderSell5,813,954$3.75$21,802,327.504,295,580  
5/21/2019Life Sciences Maste PerceptiveMajor ShareholderBuy4,000,000$4.00$16,000,000.00  
5/17/2019Adam S GrossmanInsiderBuy30,000$4.00$120,000.0037,527  
5/17/2019Brian LenzCFOBuy5,000$4.00$20,000.0025,000  
5/17/2019James MondEVPBuy4,500$4.00$18,000.0017,889  
5/17/2019Lawrence P GuiheenDirectorBuy25,000$4.00$100,000.0050,000  
6/8/2018Adam S GrossmanCEOBuy52,301$4.78$249,998.7832,527  
6/8/2018Brian LenzCFOBuy5,000$4.78$23,900.0020,000  
6/8/2018Jerrold B GrossmanDirectorBuy20,921$4.78$100,002.3898,007  
11/9/2017Adam S GrossmanInsiderBuy485,000$2.15$1,042,750.00  
11/9/2017Brian LenzCFOBuy6,500$2.15$13,975.0015,000  
11/9/2017Eric I RichmanDirectorBuy25,000$2.15$53,750.0031,300  
11/9/2017James MondCMOBuy10,000$2.15$21,500.0013,389  
5/3/2016Adam S GrossmanCEOBuy200,000$6.50$1,300,000.00  
5/3/2016Brian LenzCFOBuy2,500$6.50$16,250.008,500  
5/3/2016James MondCMOBuy770$6.50$5,005.003,389  
5/3/2016Jerrold B GrossmanDirectorBuy45,769$6.50$297,498.50  
12/8/2015Adam S. GrossmanCEOBuy500$9.00$4,500.00637,268  
12/7/2015Jerrold B GrossmanDirectorBuy500$9.01$4,505.0056,558  
12/2/2015Adam S GrossmanCEOBuy2,250$9.15$20,587.50636,768  
12/2/2015Brian LenzCFOBuy1,000$9.15$9,150.006,000  
12/2/2015Jerrold B GrossmanDirectorBuy6,000$9.16$54,960.0056,058  
12/1/2015Adam S GrossmanCEOBuy1,800$9.17$16,506.00  
11/25/2015Adam S GrossmanCEOBuy1,800$9.18$16,524.00  
11/20/2015Adam S GrossmanCEOBuy3,861$9.21$35,559.81628,418  
3/19/2015Adam S GrossmanCEOBuy2,000$8.50$17,000.00  
3/17/2015Adam S GrossmanCEOBuy5,500$7.98$43,890.00  
3/17/2015Jerrold B GrossmanDirectorBuy500$8.01$4,005.00  
3/16/2015Adam S GrossmanCEOBuy8,800$8.03$70,664.00  
3/16/2015James MondCMOBuy1,250$8.02$10,025.00  
3/16/2015Lawrence P GuiheenDirectorBuy1,000$7.96$7,960.00  
3/13/2015Eric I RichmanDirectorBuy3,500$7.88$27,580.00  
9/12/2014Adam S GrossmanCEOBuy4,300$9.57$41,151.00  
8/22/2014Adam S GrossmanCEOBuy1,000$9.50$9,500.00  
8/14/2014Adam S GrossmanCEOBuy2,100$9.77$20,517.00  
6/18/2014Adam S GrossmanCEOBuy1,875$9.59$17,981.25  
5/22/2014Adam S GrossmanCEOBuy4,226$8.15$34,441.90  
5/15/2014Adam S GrossmanCEOBuy13,400$7.50$100,500.00  
5/14/2014Brian LenzCFOBuy1,000$7.50$7,500.00  
5/14/2014James MondCMOBuy1,315$7.60$9,994.00  
12/10/2013Jerrold B GrossmanDirectorBuy3,650$7.30$26,645.00  
(Data available from 1/1/2013 forward)
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.